Uta is a Professor of Molecular Medicine and has over 25 years’ experience in developing advanced therapeutic medicines. Her research interests are related to the development of gene and cell therapy-based treatments for cystic fibrosis (CF) and other lung diseases. She has overseen vector and biomarker development, toxicology studies, as well as vector manufacturing and has been a Co-I on several clinical trials. Uta is a member of the UK Respiratory Gene Therapy Consortium (GTC) strategy group and a co-founder of AlveoGene (Imperial College Spinout) with the remit of developing gene therapy for rare respiratory diseases. In addition to her research activities she has an active role in education and workforce development related to advanced therapeutics in the UK.